Type 1 diabetes alters brain cannabinoid receptor expression and phosphorylation status in rats

Hormone and Metabolic Research

Volumn 40, Issue 7, 2008, Pages 454-458

  Diaz Asensio C ^a   Setien R ^a   Echevarria E ^a   Casis, L ^a   Casis, E ^b   Garrido, A ^b   Casis, Oscar ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b HOSPITAL DONOSTIA   (Spain)

Author keywords

Appetite; CBI; Hyperphagia; Insulin; Weight loss

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR; ENDOCANNABINOID; LEPTIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FOREBRAIN; HYPOTHALAMUS; IMMUNOCYTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; STREPTOZOCIN DIABETES; WEIGHT REDUCTION; WESTERN BLOTTING;

ANIMALS; APPETITE; BLOOD GLUCOSE; BODY WEIGHT; BRAIN; DIABETES MELLITUS, TYPE 1; EATING; LEPTIN; MALE; PHOSPHORYLATION; PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1;

ANIMALIA; RATTUS;

EID: 48349132769     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1065323     Document Type: Article

References (42)

1. Gan D, Regniers C. Eds. 2003 Diabetes Atlas. International Diabetes Federation. www.eatlas.idf.org/Prevalence/
2. Schwartz MW, Woods SC, Porte Jr D, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000; 404: 661-671
3. Berry EM, Mechoulam R. Tetrahydrocannabinol and endocannabinoids in feeding and appetite. Pharmcol Ther 2002; 95: 185-190
4. Vickers SP, Kennett GA. Cannabinoids and the regulation of ingestive behaviour. Curr Drug Targets 2005; 6: 215-223
5. Marzo V Di, Matias I. Endocannabinoid control of food intake and energy balance. Nature Neurosci 2005; 8: 585-589
6. Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev 2006; 27: 73-100
7. Williams CM, Kirkham TC. Anandamide induced overeating: mediation by central cannabinoid receptors. Psychopharmacology 1999; 143: 315-317
8. Kirkham TC, Williams CM. Synergistic efects of opioid and cannabinoid antagonists on food intake. Psychopharmacology 2001; 153: 267-270
9. Jamshidi N, Taylor DA. Anandamide administration into the ventro-medial hypothalamus stimulates appetite in rats. Brit J Pharmacol 2001; 134: 1151-1154
10. Beinfeld MC, Connolly K. Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids. Neurosci Lett 2001; 301: 69-71
11. Matias I, Gonthier MP, Orlando P, Martiadis V, Petrocellis L De, Cervino C, Petrosino S, Hoareau L, Festy F, Pasquali R, Roche R, Maj M, Pagotto U, Monteleone P, Marzo V Di. Regulation, function, and dys-regulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. J Clin Endocrinol Metab 2006; 91: 3171-3180
12. Matias I, Marzo V Di. Endocannabinoids and the control of energy balance. Trends Endocrinol Metab 2007; 18: 27-37
13. Tanda G, Pontieri FE, Chiara G Di. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a commun mu1 opioid receptor mechanism. Science 1997; 276: 2048-2050
14. Casis O, Gallego M, Iriarte M, Sanchez-Chapula JA. Effects of diabetic cardiomyopathy on regional electrophysiologic characteristics of rat ventricle. Diabetologia 2000; 43: 101-109
15. Gallego M, Casis O. Regulation of cardiac transient outward potassium current by norepinephrine in normal and diabetic rats. Diabetes-Metab Res 2001; 17: 304-309
16. Berridge KC. Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev 1996; 20: 1-25
17. Cooper SJ. Endocannabinoids and food consumption: comparisons with benzodiazepine and opioid palatability-dependent appetite. Eur J Pharmacol 2004; 500: 37-49
18. Morales M, Wang SD, Díaz-Ruiz O, Jho DH. Cannabinoid CB1 receptor and serotonin 3 receptor subunit A (5-HT3A) are co-expressed in GABA neurons in the rat telencephalon. J Comp Neurol 2004; 468: 205-216
19. Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N, Freund TF. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 2001; 21: 9506-9518
20. Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi ES, Mackie K, Freund TF. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 1999; 19: 4544-4558
21. Kokare DM, Patole A, Carta A, Chopde C, Subhedar NK. GABA(A) receptors mediate orexin-A induced stimulation of food intake. Neuropharmacology 2006; 50: 16-24
22. Epstein LH, Leddy JJ. Food reinforcement. Appetite 2006; 46: 22-25
23. Wang GJ, Volkow ND, Fowler JS. The role of dopamine in motivation for food in humans: implications for obesity. Expert Opin Ther Tar 2002; 6: 601-609
24. Kearn CS, Blake-Palmer K, Daniel E, Mackie K, Glass M. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Mol Pharmacol 2005; 67: 1697-1704
25. Harrold JA, Elliott JC, King PJ, Widdowson PS, Williams G. Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food? Brain Res 2002; 952: 232-238
26. Rodríguez de Fonseca F. The endocannabinoid system and food intake control. Rev Med Univ Nav 2004; 48: 18-23
27. Darmani NA, Janoyan JJ, Kumar N, Crim JL. Behaviourally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover. Pharmacol Biochem Behav 2003; 75: 777-787
28. Jarrahian A, Watts VJ, Barker EL. D2 dopamine receptors modulate G alpha-subunit coupling of the CB1 cannabinoid receptor. J Pharmacol Exp Ther 2004; 308: 880-886
29. Engler B, Freiman I, Urbanski M, Szabo B. Effects of exogenous and endogenous cannabinoids on GABAergic neurotransmission between the caudate-putamen and the globus pallidus in the mouse. J Pharmacol Exp Ther 2006; 316: 608-617
30. Kelley AE, Bakshi V, Haber SN, Steininger TL, Will MJ, Zhang M. Opioid modulation of taste hedonics within the ventral striatum. Physiol Behav 2002; 76: 365-377
31. Peciña S, Berridge KC. Hedonic hot spot in nucleus accumbens shell: Where do mu-opioids cause increased hedonic impact of sweetness? J Neurosci 2005; 25: 11777-11786
32. Will MJ, Franzblau B, Kelley AE. Nucleus accumbens mu-opioids regulate intake of a high-fat diet via activation of a distributed brain network. J Neurosci 2003; 23: 2882-2888
33. Pliquett RU, Fuhrer D, Falk S, Zysset S, Cramon DY Von, Stumvoll M. The effects of insulin on the central nervous system. Focus on appetite regulation. Horm Metab Res 2006; 38: 442-446
34. Cabanelos A, Lisboa PC, Moura EG, Pazos-Moura CC. Leptin acute modulation of the 5′ -deiodinase activities in hypothalamus, pituitary and brown adipose tissue of fed rats. Leptin acute modulation of the 5′-deiodinase activities in hypothalamus, pituitary and brown adipose tissue of fed rats. Horm Metab Res 2006; 38: 481-485
35. Kempf K, Hector J, Strate T, Schwarzloh B, Rose B, Herder C, Martin S, Algenstaedt P. Immune-mediated activation of the endocannabinoid system in visceral adipose tissue in obesity. Horm Metab Res 2007; 39: 596-600
36. Williams G, Harrold JA, Cutler DJ. The hypothalamus and the regulation of energy homeostasis: lifting the lid on a black box. Proc Nutr Soc 2000; 59: 385-396
37. Marzo V Di, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z, Fezza F, Miura GI, Palmiter RD, Sugiura T, Kunos G. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001; 410: 822-825
38. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-549
39. Jo YH, Chen YJJ, Chua SC, Talmage DA, Role LW. Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit. Neuron 2005; 48: 1055-1066
40. Lynch WC, Hart P, Babcock AM. Neuropeptide Y attenuates satiety: evidence from a detailed analysis of ingestive patterns. Brain Res 1994; 636: 28-34
41. Nie J, Lewis DL. Structural domains of the CB1 cannabinoid receptor that contribute to constitutive activity and G-protein sequestration. J Neurosci 2001; 21: 8758-8764
42. Garcia DE, Brown S, Hille B, Mackie K. Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor. J Neurosci 1998; 18: 2834-2841